Bauvois B, Legrand C, Caen J P
Haemostasis. 1980;9(2):92-104. doi: 10.1159/000214346.
The binding of adenosine and adenylnucleotides to the human platelet membrane has been measured and the subsequent effect on the binding of 14C-ADP has been determined. The following conclusions have been drawn: (1) Two reactions with different velocities (t 1/2 = 15--30 sec and t 1/2 = 4--6 min) seem to be involved in the binding of ADP to the platelet membrane. (2) AMP binds to the platelet membrane and partially inhibits binding of ADP in a competitive manner. These two findings suggest that ADP binding sites on the platelet membrane may be of more than one type. (3) At concentrations up to 10(-5) M, ATP does not itself bind to the platelet membrane but is rapidly transformed into ADP which, in turn, binds to the membrane and inhibits the binding of 14C-ADP. (4) Adenosine does not significantly interfere with the binding of 14C-ADP and has not been shown to bind to the platelet membrane.
已对腺苷和腺苷酸与人体血小板膜的结合进行了测定,并确定了其对(14C - ADP)结合的后续影响。得出了以下结论:(1)ADP与血小板膜的结合似乎涉及两种不同速度的反应((t_{1/2}=15 - 30)秒和(t_{1/2}=4 - 6)分钟)。(2)AMP与血小板膜结合,并以竞争方式部分抑制ADP的结合。这两个发现表明,血小板膜上的ADP结合位点可能不止一种类型。(3)在浓度高达(10^{-5}M)时,ATP本身不与血小板膜结合,但会迅速转化为ADP,而ADP又会与膜结合并抑制(14C - ADP)的结合。(4)腺苷不会显著干扰(14C - ADP)的结合,且尚未显示其与血小板膜结合。